These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 21865355)

  • 1. Continuation of amiodarone delays restoration of euthyroidism in patients with type 2 amiodarone-induced thyrotoxicosis treated with prednisone: a pilot study.
    Bogazzi F; Bartalena L; Tomisti L; Rossi G; Brogioni S; Martino E
    J Clin Endocrinol Metab; 2011 Nov; 96(11):3374-80. PubMed ID: 21865355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoids are preferable to thionamides as first-line treatment for amiodarone-induced thyrotoxicosis due to destructive thyroiditis: a matched retrospective cohort study.
    Bogazzi F; Tomisti L; Rossi G; Dell'Unto E; Pepe P; Bartalena L; Martino E
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3757-62. PubMed ID: 19622616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations.
    Bogazzi F; Bartalena L; Tomisti L; Rossi G; Tanda ML; Dell'Unto E; Aghini-Lombardi F; Martino E
    J Clin Endocrinol Metab; 2007 Feb; 92(2):556-62. PubMed ID: 17148557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study.
    Bogazzi F; Bartalena L; Cosci C; Brogioni S; Dell'Unto E; Grasso L; Aghini-Lombardi F; Rossi G; Pinchera A; Braverman LE; Martino E
    J Clin Endocrinol Metab; 2003 May; 88(5):1999-2002. PubMed ID: 12727944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of amiodarone-induced thyrotoxicosis type 2: a randomized clinical trial.
    Eskes SA; Endert E; Fliers E; Geskus RB; Dullaart RP; Links TP; Wiersinga WM
    J Clin Endocrinol Metab; 2012 Feb; 97(2):499-506. PubMed ID: 22130792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiodarone-induced thyrotoxicosis: clinical course and predictors of outcome.
    Conen D; Melly L; Kaufmann C; Bilz S; Ammann P; Schaer B; Sticherling C; Muller B; Osswald S
    J Am Coll Cardiol; 2007 Jun; 49(24):2350-5. PubMed ID: 17572251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiodarone-induced thyrotoxicosis due to destructive thyroiditis: therapeutic recommendations.
    Dietlein M; Schicha H
    Exp Clin Endocrinol Diabetes; 2005 Mar; 113(3):145-51. PubMed ID: 15789273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body mass index and the development of amiodarone-induced thyrotoxicosis in adults with congenital heart disease--a cohort study.
    Stan MN; Ammash NM; Warnes CA; Brennan MD; Thapa P; Nannenga MR; Bahn RS
    Int J Cardiol; 2013 Aug; 167(3):821-6. PubMed ID: 22386642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of thyroid function after amiodarone-induced thyrotoxicosis, as compared to subacute thyroiditis.
    Bogazzi F; Dell'Unto E; Tanda ML; Tomisti L; Cosci C; Aghini-Lombardi F; Sardella C; Pinchera A; Bartalena L; Martino E
    J Endocrinol Invest; 2006 Sep; 29(8):694-9. PubMed ID: 17033257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy.
    Bogazzi F; Bartalena L; Dell'Unto E; Tomisti L; Rossi G; Pepe P; Tanda ML; Grasso L; Macchia E; Aghini-Lombardi F; Pinchera A; Martino E
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):533-7. PubMed ID: 17561980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Amiodarone and the thyroid gland].
    Bednarek-Tupikowska G; Filus A; Kuliczkowska J; Bugajski J
    Postepy Hig Med Dosw (Online); 2004 Apr; 58():216-25. PubMed ID: 15114257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total thyroidectomy in patients with amiodarone-induced thyrotoxicosis and severe left ventricular systolic dysfunction.
    Tomisti L; Materazzi G; Bartalena L; Rossi G; Marchello A; Moretti M; De Napoli L; Mariotti R; Miccoli P; Martino E; Bogazzi F
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3515-21. PubMed ID: 22865896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An audit of amiodarone-induced thyrotoxicosis--do anti-thyroid drugs alone provide adequate treatment?
    Patel N; Inder WJ; Sullivan C; Kaye G
    Heart Lung Circ; 2014 Jun; 23(6):549-54. PubMed ID: 24613043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists.
    Tanda ML; Piantanida E; Lai A; Liparulo L; Sassi L; Bogazzi F; Wiersinga WM; Braverman LE; Martino E; Bartalena L
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):812-8. PubMed ID: 18410546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis.
    Loy M; Perra E; Melis A; Cianchetti ME; Piga M; Serra A; Pinna G; Mariotti S
    Acta Radiol; 2007 Jul; 48(6):628-34. PubMed ID: 17611870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study.
    Bartalena L; Brogioni S; Grasso L; Bogazzi F; Burelli A; Martino E
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2930-3. PubMed ID: 8768854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison Between Total Thyroidectomy and Medical Therapy for Amiodarone-Induced Thyrotoxicosis.
    Cappellani D; Papini P; Pingitore A; Tomisti L; Mantuano M; Di Certo AM; Manetti L; Marconcini G; Scattina I; Urbani C; Morganti R; Marcocci C; Materazzi G; Iervasi G; Martino E; Bartalena L; Bogazzi F
    J Clin Endocrinol Metab; 2020 Jan; 105(1):. PubMed ID: 31545358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioactive iodine in the treatment of type-2 amiodarone-induced thyrotoxicosis.
    Gursoy A; Tutuncu NB; Gencoglu A; Anil C; Demirer AN; Demirag NG
    J Natl Med Assoc; 2008 Jun; 100(6):716-9. PubMed ID: 18595575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography.
    Eaton SE; Euinton HA; Newman CM; Weetman AP; Bennet WM
    Clin Endocrinol (Oxf); 2002 Jan; 56(1):33-8. PubMed ID: 11849244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis.
    Bogazzi F; Bartalena L; Brogioni S; Mazzeo S; Vitti P; Burelli A; Bartolozzi C; Martino E
    Thyroid; 1997 Aug; 7(4):541-5. PubMed ID: 9292940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.